| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr15_0216500 | Intergenic-Intergenic | chr15:64795149-64797243 | chr15:64502950-64505044 | 2095 nt | 0.4396 |
| hsa_chr15_0216600 | Intergenic-Intergenic | chr15:64795149-64801001 | chr15:64502950-64508802 | 250 nt | 0.4400 |
| hsa_chr15_0216700 | Intergenic-Intergenic | chr15:64795149-64801013 | chr15:64502950-64508814 | 250 nt | 0.4440 |
| hsa_chr15_0216800 | Intergenic-Intergenic | chr15:64795404-64796485 | chr15:64503205-64504286 | 1082 nt | 0.4279 |
| hsa_ZNF609_0004100 | Intron-Intron | chr15:64796716-64798100 | chr15:64504517-64505901 | 1385 nt | 0.4043 |
| hsa_ZNF609_0004200 | Intron-Intron | chr15:64802174-64854057 | chr15:64509975-64561858 | 250 nt | 0.2880 |
| hsa_chr15_0216900 | Intergenic-Intergenic | chr15:64807134-64807831 | chr15:64514935-64515632 | 698 nt | 0.3897 |
| hsa_ZNF609_0004300 | Intron-Intron | chr15:64807660-64807849 | chr15:64515461-64515650 | 190 nt | 0.4316 |
| hsa_chr15_0217000 | Intergenic-Intergenic | chr15:64807962-64808174 | chr15:64515763-64515975 | 213 nt | 0.4977 |
| hsa_ZNF609_0004400 | Intron-Intron | chr15:64808854-64809757 | chr15:64516655-64517558 | 904 nt | 0.3883 |
A study in mice demonstrated that the circZNF609 exhibits higher expression in myotubes compared to myoblasts, and its downregulation reduces myoblast proliferation while inhibiting differentiation by sponging miR-194-5p and upregulating BCLAF1 [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review consolidating research across multiple species, including human, mouse, rat, and C. elegans, indicates that the circZNF609 is downregulated in Hirschsprung disease and functions as a miRNA sponge for miR-150-5p to regulate AKT3, where its silencing inhibits cell migration and proliferation [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. In mammalian neural tissue, it is also noted to play a role in myoblast differentiation by producing a protein [Suresh L. Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].